CT Myocardial Defect Assessment

Assessing myocardial defects

Relies on the automatic 3D model-based whole-heart segmentation from the CCA application to provide visual and quantitative assessment of segmented, low-attenuation areas within the left ventricle myocardium from a single, gated cardiac CTA scan.

myocardial defect assessment

Benefits

  • Volumetric visualization of coronary arteries along with segmentation maps can be displayed as an overlay on top of a 3D myocardial surface.
  • Quantitative information includes volume of low attenuation areas within the myocardium and their percentage out of the total myocardial volume.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.

Continue Cancel